With the confirmation of the anti-melanoma effect, we further explored the general applicability of imNAαPD1 & αPDL1 using a murine 4T1 mammary tumor model, which emulates stage IV human breast cancer and is otherwise unresponsive to anti-PD1/PDL1 treatment33. The gene discussed is CD274; the disease is breast carcinoma.